GSK’s Nucala receives positive CHMP opinion for treatment of chronic obstructive pulmonary disease: London, UK Monday, December 15, 2025, 16:00 Hrs [IST] GSK plc announced that ...

The best thing since sliced bread. That's how patient and former volunteer Lori Gasca describes Tri City Health Partnership, ...

A Massachusetts man in his 40s has been diagnosed with silicosis, an incurable lung disease linked to popular kitchen ...

The UCR accepts referrals from GPs, Hampshire hospitals, ambulance services, families, and patients themselves. It helps ...

GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...

GSK secures FDA approval for its oral gonorrhoea drug as EMA backs expanded RSV vaccine and additional respiratory treatments ...

An expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed seven new medicines for approval this ...

GSK PLC on Friday said the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended the approval of depemokimab in two indications. The London-based pharmaceutical ...

New research from the University of Vermont reveals exposure to smoke from Canadian wildfires in the summer of 2023 led to ...

The 76-year-old gets 15 to 20 Medicare scam calls daily. He has tried everything to stop them: blocked calls, written to ...

Priority Health, a nationally recognized nonprofit health plan serving more than 1.3 million members, has partnered with Kivo Health, a leading provider of AI-powered virtual pulmonary rehabilitation ...

Fast Track designation supported by positive results from the KT-621 BroADen Phase 1b atopic dermatitis (AD) patient trial KT-621 BROADEN2 Phase ...